Page last updated: 2024-09-04

resiquimod and Viremia

resiquimod has been researched along with Viremia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alter, G; Cohen, KW; Dugast, AS; McElrath, MJ; Stamatatos, L1
Anastassiadou, V; Kafetzis, DA; Koumbi, LJ; Machaira, M; Papadopoulos, NG; Papaevangelou, V1

Other Studies

2 other study(ies) available for resiquimod and Viremia

ArticleYear
HIV-1 single-stranded RNA induces CXCL13 secretion in human monocytes via TLR7 activation and plasmacytoid dendritic cell-derived type I IFN.
    Journal of immunology (Baltimore, Md. : 1950), 2015, Mar-15, Volume: 194, Issue:6

    Topics: Anti-Retroviral Agents; Cells, Cultured; Chemokine CXCL13; Cohort Studies; Dendritic Cells; Flow Cytometry; Gene Expression; HIV Infections; HIV-1; Host-Pathogen Interactions; Humans; Imidazoles; Interferon-alpha; Leukocytes, Mononuclear; Monocytes; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Toll-Like Receptor 7; Viremia

2015
Dendritic cells in uninfected infants born to hepatitis B virus-positive mothers.
    Clinical and vaccine immunology : CVI, 2010, Volume: 17, Issue:7

    Topics: Adult; Case-Control Studies; Dendritic Cells; Female; Flow Cytometry; Hepatitis B; Hepatitis B virus; Humans; Imidazoles; Infant; Infant, Newborn; Male; Maternal-Fetal Exchange; Mothers; Pregnancy; Viremia

2010